Relugolix + Enzalutamide Study in High-Risk Prostate Cancer

Clinical trial NCT06130995 · RECRUITING

Trial details

NCT number: NCT06130995
Sponsor: University of Oklahoma
Status: RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Androgen Deprivation Therapy Locally Advanced Prostate Cancer

Start date: 2024-12-26
Primary completion: 2029-01-01
Enrollment: 46

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.